← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Telethon Institute For Child Health Res
Subiaco
$1,650,883
Total funding
7
Grants
Funding over time
peak $149K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$1,650,883 · 7
By mechanism
R21$1,123,500 · 6
R33$527,383 · 1
Investigators at Telethon Institute For Child Health Res
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Prognosis in childhood ALL$230,304
R33 · FY2004 · CA
Prognosis in childhood ALL$148,969
R33 · FY2006 · CA
Prognosis in childhood ALL$148,110
R33 · FY2005 · CA
PLZF oncoprotein complexes specific interaction blocker$108,000
R21 · FY2002 · CA
PLZF oncoprotein complexes specific interaction blocker$108,000
R21 · FY2003 · CA
Prognosis in childhood ALL$108,000
R21 · FY2002 · CA
Prognosis in childhood ALL$108,000
R21 · FY2003 · CA
Inhibition of telomerase actiivity in breast cancer$100,000
R21 · FY2002 · CA
Mechanisms of genomic instability in cancer$100,000
R21 · FY2002 · CA
SPECIFIC PEPTIDE INHIBITION OF ONCOPROTEIN INTERACTIONS$100,000
R21 · FY2000 · CA
SPECIFIC PEPTIDE INHIBITION OF ONCOPROTEIN INTERACTIONS$100,000
R21 · FY2001 · CA
Inhibition of telomerase actiivity in breast cancer$100,000
R21 · FY2001 · CA
Mechanisms of genomic instability in cancer$100,000
R21 · FY2001 · CA
MOLECULAR GENETIC LESIONS AND CLINICAL OUTCAME IN ALL$91,500
R21 · FY2000 · CA